METAFORA Biosystems is a biotechnology company dedicated to developing the use of RBDs, which are ligands of nutrient transporters. Their tools are able to reveal subtle quantitative changes in cell physiology that are the reflection of metabolic variations induced by drugs, genetic mutations, cell culture conditions, disease etc. This technology has multiple competitive advantages in different segments of the biomarker market. METAFORA Biosystems is launching a first series of kits to address the pre-clinical research market.